4 completed, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow cytoflavin: new trials by email Literature Review of cytoflavin trials Research Report on cytoflavin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy Cytoflavin - Stroke, Acute, Stroke, Ischemic | Unknown | POLYSAN Scientific & Technological Pharmaceutical Company | 562 | 2024-03-01 | 2025-04-18 | |
| Cytoflavin in the Complex Rehabilitation of Stroke Patients Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid), Placebo - Stroke | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 240 | 2023-06-30 | 2026-04-14 |
| Cytoflavin in Combination With Reperfusion in Stroke Patients Cytoflavin (succinic acid + inosine + nicotinamide + riboflavin), Control - Acute Stroke | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 200 | 2022-04-10 | 2023-03-20 | |
| Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid), Placebo - Diabetic Neuropathies | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 216 | 2020-11-25 | 2023-01-27 |
| International Trial of Efficacy of Cytoflavin in Head Trauma Cytoflavin ((Inosine + Nicotinamide + Riboflavin + Succinic Acid), Placebo - Head Trauma,Closed | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 166 | 2020-11-22 | 2025-04-18 |
Stroke (3) · Brain Concussion (1) · Brain Injuries, Traumatic (1) · Cerebral Infarction (1) · Craniocerebral Trauma (1) · Diabetes Mellitus (1) · Diabetic Neuropathies (1) · Head Injuries, Closed (1) · Ischemic Stroke (1) · Peripheral Nervous System Diseases (1)
POLYSAN Scientific & Technological Pharmaceutical Company (5)
Russia (5) · Kazakhstan (1)
Alexander V Savello, Prof (1) · Alexey Shmonin, Prof (1) · Dina R Khasanova, prof. (1) · Igor A Strokov, Prof. (1) · Taras A Skoromets, Prof (1)